I've taken a look at the reason given in MSB trading halt anns for the last couple of years:
Oct 2019 - proposed financing
May 2020 - proposed equity financing
Aug 2020 - upcoming meeting of ODAC
Oct 2020 - BLA review
Yesterday - corporate update
They were reasonably specific previously. Also no trading pauses previously as they dropped before or after market. This feels different - good different or bad different is the (literal) million dollar question.
I'll take a guess and say they received advice from FDA or DSMB regarding rem-l covid trial. The delay will be the result of consultation with Novartis, who now have a big stake in the outcome and will want to be consulted.
Ann: Trading halt, page-611
-
- There are more pages in this discussion • 186 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.226M | 3.581M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 13475 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 17245 | 8 |
View Market Depth
| Last trade - 13.37pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |